Healthy volunteers to test safety of experimental drug BW-20805-2
NCT ID NCT07528053
First seen Apr 17, 2026 · Last updated May 23, 2026 · Updated 4 times
Summary
This early-stage study tests whether a single injection of the experimental drug BW-20805-2 is safe and how it behaves in the body. It involves 24 healthy adults aged 18 to 60. The main goal is to check for side effects, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Argo Investigative Site
Melbourne, Victoria, 3004, Australia
Conditions
Explore the condition pages connected to this study.